PERKINELMER INC (PKI) Stock Fundamental Analysis
USA - NYSE:PKI - US7140461093 - Common Stock
115.24 USD
-1.06 (-0.91%)
115.24 USD
0 (0%)
Taking everything into account, PKI scores 5 out of 10 in our fundamental rating. PKI was compared to 55 industry peers in the Life Sciences Tools & Services industry. While PKI belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. PKI has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year PKI was profitable.
In the past year PKI had a positive cash flow from operations.
In the past 5 years PKI has always been profitable.
Each year in the past 5 years PKI had a positive operating cash flow.
1.2 Ratios
PKI has a better Return On Assets (5.28%) than 76.19% of its industry peers.
PKI has a better Return On Equity (10.11%) than 77.78% of its industry peers.
PKI has a Return On Invested Capital of 6.49%. This is in the better half of the industry: PKI outperforms 73.02% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PKI is significantly above the industry average of 15.96%.
The last Return On Invested Capital (6.49%) for PKI is well below the 3 year average (52.37%), which needs to be investigated, but indicates that PKI had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.28% | ||
| ROE | 10.11% | ||
| ROIC | 6.49% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
1.3 Margins
PKI has a better Profit Margin (16.32%) than 82.54% of its industry peers.
In the last couple of years the Profit Margin of PKI has grown nicely.
PKI has a Operating Margin of 23.43%. This is amongst the best in the industry. PKI outperforms 88.89% of its industry peers.
PKI's Operating Margin has improved in the last couple of years.
PKI has a better Gross Margin (58.39%) than 76.19% of its industry peers.
PKI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.43% | ||
| PM (TTM) | 16.32% | ||
| GM | 58.39% |
OM growth 3Y19.66%
OM growth 5Y11.6%
PM growth 3Y29.61%
PM growth 5Y5.8%
GM growth 3Y7.46%
GM growth 5Y4.78%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PKI is creating value.
The number of shares outstanding for PKI remains at a similar level compared to 1 year ago.
The debt/assets ratio for PKI has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.51 indicates that PKI is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of PKI (2.51) is comparable to the rest of the industry.
The Debt to FCF ratio of PKI is 7.40, which is on the high side as it means it would take PKI, 7.40 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.40, PKI is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
A Debt/Equity ratio of 0.53 indicates that PKI is somewhat dependend on debt financing.
The Debt to Equity ratio of PKI (0.53) is worse than 68.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 7.4 | ||
| Altman-Z | 2.51 |
ROIC/WACC0.65
WACC10.02%
2.3 Liquidity
PKI has a Current Ratio of 2.13. This indicates that PKI is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PKI (2.13) is worse than 68.25% of its industry peers.
PKI has a Quick Ratio of 1.87. This is a normal value and indicates that PKI is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of PKI (1.87) is worse than 65.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.13 | ||
| Quick Ratio | 1.87 |
3. Growth
3.1 Past
PKI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.47%.
Measured over the past years, PKI shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.15% on average per year.
PKI shows a decrease in Revenue. In the last year, the revenue decreased by -3.37%.
The Revenue has been growing slightly by 7.97% on average over the past years.
EPS 1Y (TTM)-30.47%
EPS 3Y24.65%
EPS 5Y22.15%
EPS Q2Q%-33.59%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y4.72%
Revenue growth 5Y7.97%
Sales Q2Q%-27.89%
3.2 Future
The Earnings Per Share is expected to grow by 6.04% on average over the next years.
PKI is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -8.60% yearly.
EPS Next Y-34.36%
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
EPS Next 5Y6.04%
Revenue Next Year-31.32%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.6%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 14.51, which indicates a correct valuation of PKI.
Based on the Price/Earnings ratio, PKI is valued cheaper than 96.83% of the companies in the same industry.
PKI's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.27.
A Price/Forward Earnings ratio of 22.11 indicates a rather expensive valuation of PKI.
Based on the Price/Forward Earnings ratio, PKI is valued a bit cheaper than 77.78% of the companies in the same industry.
PKI is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.77, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.51 | ||
| Fwd PE | 22.11 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PKI is valued cheaply inside the industry as 93.65% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PKI indicates a rather cheap valuation: PKI is cheaper than 87.30% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.52 | ||
| EV/EBITDA | 12.35 |
4.3 Compensation for Growth
The excellent profitability rating of PKI may justify a higher PE ratio.
PKI's earnings are expected to decrease with -4.57% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.66
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
5. Dividend
5.1 Amount
No dividends for PKI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
115.24
-1.06 (-0.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners86.56%
Inst Owner Change-9.19%
Ins Owners0.81%
Ins Owner Change0%
Market Cap14.57B
Analysts73
Price Target159.39 (38.31%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP4.74%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.02%
Min EPS beat(2)2.33%
Max EPS beat(2)3.7%
EPS beat(4)4
Avg EPS beat(4)8.57%
Min EPS beat(4)2.33%
Max EPS beat(4)14.5%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-29.78%
Min Revenue beat(2)-30.42%
Max Revenue beat(2)-29.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.3%
Min Revenue beat(4)-30.42%
Max Revenue beat(4)52.86%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.68%
PT rev (3m)-2.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.24%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-17.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.51 | ||
| Fwd PE | 22.11 | ||
| P/S | 3.19 | ||
| P/FCF | 24.52 | ||
| P/OCF | 21.43 | ||
| P/B | 1.97 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.35 |
EPS(TTM)7.94
EY6.89%
EPS(NY)5.21
Fwd EY4.52%
FCF(TTM)4.7
FCFY4.08%
OCF(TTM)5.38
OCFY4.67%
SpS36.16
BVpS58.4
TBVpS-19.59
PEG (NY)N/A
PEG (5Y)0.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.28% | ||
| ROE | 10.11% | ||
| ROCE | N/A | ||
| ROIC | 6.49% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 35.96% | ||
| OM | 23.43% | ||
| PM (TTM) | 16.32% | ||
| GM | 58.39% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
ROICexc(3y)8.57%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0.99%
ROICexcg growth 5Y-8%
ROICexc growth 3Y-3.25%
ROICexc growth 5Y0.67%
OM growth 3Y19.66%
OM growth 5Y11.6%
PM growth 3Y29.61%
PM growth 5Y5.8%
GM growth 3Y7.46%
GM growth 5Y4.78%
F-Score7
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 7.4 | ||
| Debt/EBITDA | 2.93 | ||
| Cap/Depr | 20.05% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | 79.63% | ||
| Current Ratio | 2.13 | ||
| Quick Ratio | 1.87 | ||
| Altman-Z | 2.51 |
F-Score7
WACC10.02%
ROIC/WACC0.65
Cap/Depr(3y)26.47%
Cap/Depr(5y)33.81%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)118.43%
Profit Quality(5y)114.16%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.47%
EPS 3Y24.65%
EPS 5Y22.15%
EPS Q2Q%-33.59%
EPS Next Y-34.36%
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
EPS Next 5Y6.04%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y4.72%
Revenue growth 5Y7.97%
Sales Q2Q%-27.89%
Revenue Next Year-31.32%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.6%
Revenue Next 5YN/A
EBIT growth 1Y-24.58%
EBIT growth 3Y25.31%
EBIT growth 5Y20.49%
EBIT Next Year-23.7%
EBIT Next 3Y-3.21%
EBIT Next 5Y3.97%
FCF growth 1Y-54.67%
FCF growth 3Y28.17%
FCF growth 5Y18.96%
OCF growth 1Y-51.81%
OCF growth 3Y23.2%
OCF growth 5Y18.7%